Cerberus<\/a>, the New York distressed-debt giant, is among bidders vying to take over a potential sale of a portfolio of the bank\u2019s non-performing loans. <\/p>\nBank of Ireland lost almost 1 per cent to close at \u20ac13.76 per share. <\/p>\n
Ryanair dipped 0.6 per cent to \u20ac23.85 per share.<\/p>\n
Meanwhile, housebuilders Cairn Homes and Glenveagh Properties advanced, adding 1.6 per cent and 2.7 per cent respectively. <\/p>\n
Healthcare group Uniphar jumped 1.8 per cent to \u20ac3.90 per share while Kerry Group advanced to \u20ac76.95 per share, up 1.6 per cent.<\/p>\n
EUROPE<\/p>\n
The blue-chip Stoxx 50 index and the pan-European Stoxx 600 finished 0.3 per cent higher.<\/p>\n
European miners climbed, tracking higher metal prices, with gold at a record high and copper prices in London also gaining. Tara Mines owner Boliden jumped 4.5 per cent while its Swedish peer Sandvik added 0.3 per cent.<\/p>\n
Technology stocks gained, with chipmakers ASMI, ASML, and BE Semiconductor up by between 1.8 per cent and 3 per cent.<\/p>\n
Luxury stocks also jumped. Shares in Kering rose by nearly 4 per cent to their highest level this year on optimism that new chief executive, Luca de Meo, can turn the struggling Gucci owner\u2019s fortunes around.<\/p>\n
Ray-Ban maker Essilor Luxottica, LVMH and Hermes were all up by between 1.5 per cent and 2.4 per cent.<\/p>\n
European stocks cheered the US Federal Reserve\u2019s first interest rate cut of 2025 earlier this month, but remain more than 1 per cent away from their all-time highs, falling behind Wall Street.<\/p>\n
LONDON<\/p>\n
UK stocks rose with the benchmark FTSE 100 inching 0.1 per cent higher while the mid-cap FTSE 250 added 0.7 per cent. <\/p>\n
Health shares led broad-based gains, while investors focused on a potential US government shutdown that could delay key economic data.<\/p>\n
Pharmaceutical giant GSK\u2019s shares rose 2.3 per cent following an announcement that chief executive Emma Walmsley will step down in December and be replaced by company insider Luke Miels.<\/p>\n
Meanwhile, heavyweight AstraZeneca rose 1 per cent after revealing plans to directly list on the New York Stock Exchange, though the company emphasised it will maintain its London listing and headquarters.<\/p>\n
Precious metal miners also jumped on rising gold prices with Rio Tinto, Anglo American and Antofagasta all ahead by between 1.7 per cent and 5.3 per cent. <\/p>\n
NEW YORK<\/p>\n
Wall Street\u2019s main indices were mixed, with the Nasdaq Composite up by 0.5 per cent while the S&P 500 edged 0.2 per cent higher and the Dow Jones Industrial Average dipped by 0.1 per cent. <\/p>\n
A potentially turbulent week lies ahead, with a slew of officials from both the Fed and the European Central Bank set to speak as investors eye a US government shutdown. <\/p>\n
Wall Street largely shrugged off those anxieties, however, with tech and communication sector stocks advancing.<\/p>\n
Nvidia rose 2.8 per cent, while Micron Technology added 4.9 per cent. Lam Research advanced 2.6 per cent, after Deutsche Bank upgraded the rating on the chip-making equipment firm to \u201cbuy\u201d from \u201chold\u201d.<\/p>\n
Meanwhile, losses in stocks such as Chevron, down 2.3 per cent, and McDonald\u2019s, down 0.7 per cent, weighed on the Dow. \u2013 Additional reporting: Reuters, Bloomberg<\/p>\n","protected":false},"excerpt":{"rendered":"World shares advanced on Monday, extending September\u2019s rally in a session that finished on a note of caution…\n","protected":false},"author":2,"featured_media":460835,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5311],"tags":[10782,8295,112091,73336,22117,7372,154341,146944,154340,13279,35529,3359,1339,135912,49,978,659],"class_list":{"0":"post-460834","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-united-states","8":"tag-aib","9":"tag-astrazeneca","10":"tag-bank-of-ireland","11":"tag-cairn-homes","12":"tag-chevron","13":"tag-federal-reserve","14":"tag-glenveagh-homes","15":"tag-gsk","16":"tag-kerry-group","17":"tag-lvmh","18":"tag-mcdonalds","19":"tag-nvidia","20":"tag-ryanair","21":"tag-uniphar","22":"tag-united-states","23":"tag-us","24":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115288497475650253","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/460834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=460834"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/460834\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/460835"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=460834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=460834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=460834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}